Integrin AvB6 inhibiting Peptide
Invented at Queen Mary University of London
- Datasheet
- References (2)
- Inventor Info
Info
| Catalogue Number | 151860 |
| Relevance | αvβ6 is a major new target for molecular-specific imaging and therapy of cancer. It is expressed only on epithelia and then usually only during processes of tissue remodelling; these include wound healing, chronic inflammation, and cancer. The αvβ6 inhibiting peptide could not only permit diagnostic imaging, but also to deliver anticancer therapy specifically to tumour cells while sparing local normal tissues. |
| Antigen/Gene or Protein Targets | Integrin AvB6 inhibiting peptide |
| Research Area | Cancer, Cell Structure and Motility |
References: 2 entries
Saha et al. 2010. J Pathol. 222(1):52-63. PMID: 20629113.
High-resolution in vivo imaging of breast cancer by targeting the pro-invasive integrin alphavbeta6.
Europe PMC ID: 20629113
Add a reference
References: 2 entries
Saha et al. 2010. J Pathol. 222(1):52-63. PMID: 20629113.
High-resolution in vivo imaging of breast cancer by targeting the pro-invasive integrin alphavbeta6.
Add a reference
